Christina Boville

Christina Boville is currently the Co-Founder and CEO at Aralez Bio. Prior to this, they were a Resnick Institute Postdoctoral Fellow at Caltech from February 2017 to May 2019. Her research focused on small molecule effectors of toll-like receptors. Christina also pursued a PhD in Biochemistry at the University of Colorado at Boulder from January 2011 to December 2016. Her advisor was Hubert Yin and they studied Host cell DNA Quantification Assays using ABI7900. Christina began their professional career as a Research Associate at Amgen from May 2010 to April 2011. Christina was then a Laboratory Scientist at CaridianBCT from February 2010 to May 2010.

Christina Boville has a PhD in Biochemistry from the University of Colorado Boulder. Christina also has a B.A. in Molecular; Cellular, and Developmental Biology from the same school.

Some individuals on their team include Frances Arnold - Co-Founder, David Romney - Co-Founder & CTO.